Citations 7

TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau

Proceedings of the National Academy of Sciences | February 22, 2021 | Volume: 118 | Issue: 9 | Pages: No page available

10.1073/pnas.2014188118 | PMID 33619090

Significance Phase separation of proteins is increasingly thought to play a fundamental role in biological processes. Recent studies show that tau protein phase separates, but the biological significance is unknown since artificial crowding agents are typically used and the resulting tau is not toxic. We now demonstrate that TIA1 potentiates RNA-mediated phase separation of tau, thereby enabling a process that occurs at physiological concentrations and also directs the formation of biologically active, highly neurotoxic oligomeric tau. Coordinated phase separation of functionally related proteins provides a general mechanism through which membraneless organelles can direct biological activities.
Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology

Toxicological Sciences | October 26, 2018 | Volume: 167 | Issue: 1 | Pages: 105-115

10.1093/toxsci/kfy267 | PMID 30371865

[O2–03–03]: TAU‐INDUCED NEURODEGENERATION IS MEDIATED BY RNA BINDING PROTEINS

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2017.07.157

O4‐12‐05: Interaction between microtubule‐associated protein tau and RNA binding proteins stimulates tau misfolding and stress granule formation

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_6 | Pages: No page available

10.1016/j.jalz.2015.07.417

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

Neurology | September 12, 2013 | Volume: 81 | Issue: 15 | Pages: 1332-1341

10.1212/wnl.0b013e3182a8250c | PMID 24027057

O1‐07‐03: Structure/function analysis of TDP‐43 neurotoxicity in C. elegans

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2010.05.251

Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity

Proceedings of the National Academy of Sciences | April 21, 2009 | Volume: 106 | Issue: 18 | Pages: 7607-7612

10.1073/pnas.0900688106 | PMID 19383787

Inclusions of TAR DNA-binding protein-43 (TDP-43), a nuclear protein that regulates transcription and RNA splicing, are the defining histopathological feature of frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-Us) and sporadic and familial forms of amyotrophic lateral sclerosis (ALS). In ALS and FTLD-U, aggregated, ubiquitinated, and N-terminally truncated TDP-43 can be isolated from brain tissue rich in neuronal and glial cytoplasmic inclusions. The loss of TDP-43 function resulting from inappropriate cleavage, translocation from the nucleus, or its sequestration into inclusions could play important roles in neurodegeneration. However, it is not known whether TDP-43 fragments directly mediate toxicity and, more specifically, whether their abnormal aggregation is a cause or consequence of pathogenesis. We report that the ectopic expression of a ≈25-kDa TDP-43 fragment corresponding to the C-terminal truncation product of caspase-cleaved TDP-43 leads to the formation of toxic, insoluble, and ubiquitin- and phospho-positive cytoplasmic inclusions within cells. The 25-kDa C-terminal fragment is more prone to phosphorylation at S409/S410 than full-length TDP-43, but phosphorylation at these sites is not required for inclusion formation or toxicity. Although this fragment shows no biological activity, its exogenous expression neither inhibits the function nor causes the sequestration of full-length nuclear TDP-43, suggesting that the 25-kDa fragment can induce cell death through a toxic gain-of-function. Finally, by generating a conformation-dependent antibody that detects C-terminal fragments, we show that this toxic cleavage product is specific for pathologic inclusions in human TDP-43 proteinopathies.